Inari Medical Inc (NARI)
47.69
+0.02
(+0.04%)
USD |
NASDAQ |
May 23, 12:25
Inari Medical Enterprise Value: 2.670B for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 22, 2024 | 2.670B |
May 21, 2024 | 2.557B |
May 20, 2024 | 2.581B |
May 17, 2024 | 2.559B |
May 16, 2024 | 2.590B |
May 15, 2024 | 2.631B |
May 14, 2024 | 2.544B |
May 13, 2024 | 2.549B |
May 10, 2024 | 2.442B |
May 09, 2024 | 2.369B |
May 08, 2024 | 2.330B |
May 07, 2024 | 2.388B |
May 06, 2024 | 2.331B |
May 03, 2024 | 2.342B |
May 02, 2024 | 2.340B |
May 01, 2024 | 2.317B |
April 30, 2024 | 2.070B |
April 29, 2024 | 2.105B |
April 26, 2024 | 2.132B |
April 25, 2024 | 2.107B |
April 24, 2024 | 2.113B |
April 23, 2024 | 2.051B |
April 22, 2024 | 2.099B |
April 19, 2024 | 2.137B |
April 18, 2024 | 2.140B |
Date | Value |
---|---|
April 17, 2024 | 2.143B |
April 16, 2024 | 2.167B |
April 15, 2024 | 2.189B |
April 12, 2024 | 2.264B |
April 11, 2024 | 2.307B |
April 10, 2024 | 2.397B |
April 09, 2024 | 2.403B |
April 08, 2024 | 2.378B |
April 05, 2024 | 2.343B |
April 04, 2024 | 2.354B |
April 03, 2024 | 2.406B |
April 02, 2024 | 2.577B |
April 01, 2024 | 2.635B |
March 31, 2024 | 2.682B |
March 28, 2024 | 2.665B |
March 27, 2024 | 2.632B |
March 26, 2024 | 2.557B |
March 25, 2024 | 2.341B |
March 22, 2024 | 2.453B |
March 21, 2024 | 2.506B |
March 20, 2024 | 2.536B |
March 19, 2024 | 2.507B |
March 18, 2024 | 2.297B |
March 15, 2024 | 2.241B |
March 14, 2024 | 2.245B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.993B
Minimum
May 22 2020
6.069B
Maximum
Mar 11 2021
3.529B
Average
3.419B
Median
Dec 19 2023
Enterprise Value Benchmarks
Conmed Corp | 3.266B |
SI-BONE Inc | 456.39M |
Stereotaxis Inc | 160.56M |
Electromed Inc | 129.03M |
Myomo Inc | 106.03M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -24.20M |
Revenue (Quarterly) | 143.19M |
Total Expenses (Quarterly) | 151.29M |
EPS Diluted (Quarterly) | -0.42 |
Gross Profit Margin (Quarterly) | 86.81% |
Profit Margin (Quarterly) | -16.90% |
Earnings Yield | -0.86% |
Normalized Earnings Yield | -0.6625 |